Eli Lilly’s Mounjaro Launch: Will $50 Anti-Diabetic Vial Succeed In India?
Eli Lilly has officially launched Mounjaro (Tirzepatide) in India, marking a major milestone in the fight ...
Read more
Tag: Eli Lilly and Company
All the financial and stock market information summarised at one place for you for making better investment decisions.